Literature DB >> 9010035

Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization.

J C Rockett1, K Larkin, S J Darnton, A G Morris, H R Matthews.   

Abstract

The derivation of permanent cell lines from 40 resected oesophageal carcinomas has been attempted. Five long-term lines have been established from three adenocarcinomas, one mixed carcinoma and one squamous carcinoma. Molecular and cellular analyses have been carried out on the lines and clones derived from them. Karyotype analysis indicates genetic variation among the clones. HLA-A, -B and -C is expressed constitutively, but not HLA-DR. ICAM-1-expressing phenotypes may have arisen during adaptation to long-term culture. All lines are capable of response to interferon-gamma (IFN-gamma) and all produce transforming growth factor beta 1 (TGF-beta 1). Two lines are resistant to the inhibitory growth effects of the latter, possibly contributing to malignancy. It is anticipated that these lines, originating from histologically different carcinomas, will provide a valuable, continuous resource for the investigation and treatment of these aggressive tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010035      PMCID: PMC2063267          DOI: 10.1038/bjc.1997.42

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  The ultrastructure of oesophageal carcinomas: multidirectional differentiation. A transmission electron microscopic study of 43 cases.

Authors:  J Newman; G N Antonakopoulos; S J Darnton; H R Matthews
Journal:  J Pathol       Date:  1992-06       Impact factor: 7.996

2.  Characterization of 21 newly established esophageal cancer cell lines.

Authors:  Y Shimada; M Imamura; T Wagata; N Yamaguchi; T Tobe
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

Review 3.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

4.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Activation by interferon-gamma of expression of ICAM-1 and MHC class II antigens in tumour cells from colorectal carcinomas.

Authors:  I Donnellan; J Cantrill; I Fraser; A Morris
Journal:  Clin Mol Pathol       Date:  1995-02

6.  Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.

Authors:  R Darley; A Morris; J Passas; W Bateman
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

Review 7.  Natural history of HLA expression during tumour development.

Authors:  F Garrido; T Cabrera; A Concha; S Glew; F Ruiz-Cabello; P L Stern
Journal:  Immunol Today       Date:  1993-10

8.  A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression.

Authors:  J Jouanneau; G Moens; Y Bourgeois; M F Poupon; J P Thiery
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.

Authors:  J C Rockett; S J Darnton; J Crocker; H R Matthews; A G Morris
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

10.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Authors:  W J Blot; S S Devesa; R W Kneller; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

View more
  45 in total

1.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

2.  Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

Authors:  Jurriaan B Tuynman; Christianne J Buskens; Kristel Kemper; Fiebo J W ten Kate; G Johan A Offerhaus; Dirk J Richel; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.

Authors:  Paras Jethwa; Mushal Naqvi; Robert G Hardy; Neil-A Hotchin; Sally Roberts; Robert Spychal; Chris Tselepis
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

4.  PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.

Authors:  Vaishali Kapoor; Abhay Kumar Singh; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

5.  Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.

Authors:  Peter C Konturek; Agnieszka Nikiforuk; Joanna Kania; Martin Raithel; Eckhart Georg Hahn; Steffen Mühldorfer
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

6.  Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.

Authors:  Vaishali Kapoor; David Y A Dadey; Kim Nguyen; Scott A Wildman; Kelly Hoye; Arpine Khudanyan; Nilantha Bandara; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

7.  Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.

Authors:  Hector Alvarez; Jan-Bart M Koorstra; Seung-Mo Hong; Jurjen J Boonstra; Winand N M Dinjens; Arlene A Foratiere; Tsung-Teh Wu; Elizabeth Montgomery; James R Eshleman; Anirban Maitra
Journal:  Cancer Biol Ther       Date:  2008-11-04       Impact factor: 4.742

Review 8.  Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Authors:  Joerg Theisen; Jeffrey H Peters; Hubert J Stein
Journal:  World J Surg       Date:  2003-07-17       Impact factor: 3.352

9.  Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo.

Authors:  Elena Piazuelo; Paula Esquivias; Alba De Martino; Carmelo Cebrián; Blanca Conde; Sonia Santander; Sonia Emperador; María Asunción García-González; Patricia Carrera-Lasfuentes; Angel Lanas
Journal:  Dig Dis Sci       Date:  2016-06-24       Impact factor: 3.199

10.  Curcumin induces apoptosis-independent death in oesophageal cancer cells.

Authors:  G O'Sullivan-Coyne; G C O'Sullivan; T R O'Donovan; K Piwocka; S L McKenna
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.